# AbbVie Inc. - Inspection Records

Source: https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e

> Inspection records and compliance data for AbbVie Inc. in North Chicago, Illinois. Access full analysis and detailed observations.

---

## Details

- Name: AbbVie Inc.
- FEI Number: 3009751352
- City: North Chicago
- State: Illinois
- Country Name: United States
- Address Line 1: 1 N Waukegan Rd
- Zip Code: 60064
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1299008 - AbbVie Inc. - 2026-04-27](https://www.keypedia.com/records/fda_inspections/abbvie-inc/64d362ca-4924-4cf2-8bc0-85ea4d863db0) — source: FDA, date: April 27, 2026
- [FDA Inspection 1302298 - AbbVie Inc. - 2026-04-02](https://www.keypedia.com/records/fda_inspections/abbvie-inc/00651199-0676-4364-ac4b-a2e38a34895a) — source: FDA, date: April 2, 2026
- [FDA Inspection 1277010 - AbbVie Inc. - 2025-08-21](https://www.keypedia.com/records/fda_inspections/abbvie-inc/d998b409-04ec-4d4c-8b31-fbb0807bde69) — source: FDA, date: August 21, 2025
- [FDA Inspection 1277010 - AbbVie Inc. - 2025-08-21](https://www.keypedia.com/records/fda_inspections/abbvie-inc/20aba2c4-bf11-4f96-ab4a-2bff02a0efb6) — classification: No Action Indicated (NAI), source: FDA, date: August 21, 2025
- [FDA Inspection 1257605 - AbbVie Inc. - 2025-06-12](https://www.keypedia.com/records/fda_inspections/abbvie-inc/48e53750-1fe1-4280-8d26-fdff5c926853) — source: FDA, date: June 12, 2025
- [FDA Inspection 1257605 - AbbVie Inc. - 2025-06-12](https://www.keypedia.com/records/fda_inspections/abbvie-inc/d600c417-90fe-4fef-ae17-05d2b6b5bb8b) — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2025
- [FDA Inspection 1230795 - AbbVie Inc. - 2025-02-18](https://www.keypedia.com/records/fda_inspections/abbvie-inc/67c3b515-c0ea-487d-a385-558dd66f3031) — source: FDA, date: February 18, 2025
- [FDA Inspection 1231413 - AbbVie Inc. - 2024-04-19](https://www.keypedia.com/records/fda_inspections/abbvie-inc/4ca71b89-5c89-429d-9638-1f7bd6e022c9) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2024
- [483 - AbbVie Inc. - 2023-01-31](https://www.keypedia.com/records/483/abbvie-inc/51b48e1e-9723-4387-b252-4cc5015026fd) — source: FDA, date: January 31, 2023
- [FDA Inspection 1198013 - AbbVie Inc. - 2023-01-31](https://www.keypedia.com/records/fda_inspections/abbvie-inc/d2e8d086-0765-4436-8915-dc0a19feb201) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2023
- [FDA Inspection 1198013 - AbbVie Inc. - 2023-01-31](https://www.keypedia.com/records/fda_inspections/abbvie-inc/54654ce6-6050-43ed-a173-2eff6517407c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2023
- [EIR - AbbVie Inc. - 2021-12-15](https://www.keypedia.com/records/eir/abbvie-inc/4ea67f2c-2701-4a6c-b4a3-6225b781f7a3) — source: FDA, date: December 15, 2021
- [EIR - AbbVie Inc. - 2019-02-15](https://www.keypedia.com/records/eir/abbvie-inc/e854b1d5-8667-473b-aea4-d77c030613dc) — source: FDA, date: February 15, 2019
- [EIR - AbbVie Inc. - 2018-07-02](https://www.keypedia.com/records/eir/abbvie-inc/d5fd9956-7bc9-426d-8892-df6415f4b92b) — source: FDA, date: July 2, 2018
- [483 - AbbVie Inc. - 2018-07-02](https://www.keypedia.com/records/483/abbvie-inc/3b96cb46-4514-4018-a787-d89fad0a8d6f) — source: FDA, date: July 2, 2018
- [EIR - AbbVie Inc. - 2017-12-15](https://www.keypedia.com/records/eir/abbvie-inc/670afc69-446b-472a-b6de-83d020c0613a) — source: FDA, date: December 15, 2017
- [483 - AbbVie Inc. - 2017-12-15](https://www.keypedia.com/records/483/abbvie-inc/0596cbbe-5bd3-4926-bb9d-5e5d61b58ba4) — source: FDA, date: December 15, 2017

## Related Companies

- [Thymoorgan Pharmazie Gmbh](https://www.keypedia.com/companies/thymoorgan-pharmazie-gmbh/b58b84eb-57d4-4730-8fbb-58632f71023d)
- [Sunrise Pharmaceutical, Inc.](https://www.keypedia.com/companies/sunrise-pharmaceutical-inc/3e90c0a2-44c0-46f7-a6ff-ee1377824088)
- [OrBion Pharmaceuticals Private Limited](https://www.keypedia.com/companies/orbion-pharmaceuticals-private-limited/1cdc049d-587c-4283-8d5c-8604cff032c9)
- [Corden Pharma S.p.A.](https://www.keypedia.com/companies/corden-pharma-spa/9ebac113-b666-42f4-bce9-0183154975f3)
- [Ophtapharm AG](https://www.keypedia.com/companies/ophtapharm-ag/bf7065a3-51c2-4dd4-bcac-c2e0ab295ec4)
- [Haupt Pharma Muenster GmbH](https://www.keypedia.com/companies/haupt-pharma-muenster-gmbh/09cdc4cc-6cbc-4904-baa2-d4013dae9741)
- [KVP Pharma Veterin Produkte GmbH](https://www.keypedia.com/companies/kvp-pharma-veterin-produkte-gmbh/324116fb-c3fa-4260-9482-32b14b045106)
- [Micro Labs Limited](https://www.keypedia.com/companies/micro-labs-limited/62f2df1c-2c1e-4f8b-b4f7-40cf329f9298)
- [Cenexi](https://www.keypedia.com/companies/cenexi/14746111-88b0-4fb3-9892-19407224ae9e)
- [Corden Pharma Fribourg SA](https://www.keypedia.com/companies/corden-pharma-fribourg-sa/749b4152-5491-45ed-8d48-4e05eeb96606)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michele-perry-williams/80741e95-8df3-41c9-b9b8-499fcb97921d)
- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)
- [company_representative](https://www.keypedia.com/people/chad-ballard/27b6f31e-3b1d-468e-936d-fc531e8d3bf4)
- [company_representative](https://www.keypedia.com/people/scott-page/33111b5b-0fb4-4def-b3b2-2fe5e22a9168)
- [Vice President](https://www.keypedia.com/people/vicki-r-edwards/05433d7f-c420-4bc2-988b-7029e04ff6be)
- [Quality Program Specialist/Program Analyst](https://www.keypedia.com/people/lequita-mayhew/7c553294-3678-4771-acb4-92c4b8fbc0b1)